This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 


Click the thumbnails below to view the World IP Review and Life Sciences IP Review annuals.


World IP Review Annual 2015 


  • A decade of IP developments
  • Wated: strong IP standards
  • Working towards consensus
  • For the benefit of brand owners and consumers
  • A changing world: computer-implemented inventions


World IP Review Annual 2014


  • The 21st century patent attorney
  • Policing the pirates
  • The increasing impact of 'patent trolls' 
  • Interpreting China's new trademark law
  • India: an evolving landscape


 World IP Review Annual 2013


  • The Chinese trademark conundrum:
    will a new law solve the current problems?
  • Defending your brand turf online
  • Widening the net: the case for outsourcing
  • Future pain for patent NPEs
  • The fine line between drugs and supplements


Life Sciences IP Review Annual 2013


  • India: a threat to an industry or just misunderstood?
  • Considerations for biopharma under a
    first-inventor-to-file regime
  • Patent protection of traditional knowledge and
    biological material
  • The European take on the Bolar provision


World IP Review Annual 2012


  • Should applicants now avoid the EPO?
  • Top dogs: the General Court and OHIM
  • Anti-counterfeiting efforts in Mexico
  • Finding equilibrium: IP vs the Internet
  • Bad faith in Hong Kong


Life Sciences IP Review Annual 2012


  • Is there life for medical diagnostic patents after
  • Out in front: the Boston Cluster
  • India’s first compulsory licence
  • The importance of prior art searches


 World IP Review Annual 2011


  • Big pharma and Section 337: the next frontier
  • Social-networking sites: opportunities and challenges
    for brand owners
  • Design registrability in Hong Kong
  • Choosing a European patent attorney: does the
    Iron Curtain still exist?


 Life Sciences IP Review Annual 2011


  • An interview with BIO president Jim Greenwood
  • How shifting IP laws change the global life sciences
    regulatory chessboard
  • Practice points in Israel patent prosecution
  • Clinical trials and stratified medicine—
    Maximising patent exclusivity


 World IP Review Annual 2010


  • Domain Name Disputes—an Australian Perspective
  • New regulations for registering
    domain names in China
  • The ‘open litis principle’ in Mexican IP cases
  • When comparison becomes defamation


 Life Sciences IP Review Annual 2010


  • Myriad issues for gene patents
  • EPO oppositions: a cost-effective
    alternative to litigation
  • Stricter examination requirements in Canada
  • Clarifying patentability for medical and
    surgical developments


 World IP Review Annual 2009


  • Search engines and the question of
    trademark infringement
  • Translation: emerging markets today for
    business tomorrow
  • Norway accedes to the European Patent Convention
  • Speeding up patent applications in Japan


 Life Sciences IP Review Annual 2009


  • Questions of human embryo research
  • Patenting trends in the vaccine industry
  • The UK Patents Court:
    a more inventive jurisdiction?
  • The patentability of stem cells


 World IP Review Annual 2008


  • The importance of trademark audits
  • Winning patent disputes
  • Monitoring opportunity in an IP portfolio
  • Trademarks in cyberspace


 Life Sciences IP Review Annual 2008


  • Assuring the integrity of a supply chain
    against global threats
  • IP on the smallest scale
  • What makes a good expert witness?
  • Supplementary protection certificates
    for medicinal products


 World IP Review Annual 2007


  • Your Intellectual Property. What’s it worth?
  • Defending your brand online
  • Three-dimensional trademarks and industrial designs
  • Structuring franchise and relationships in Russia


 World IP Review Annual 2006


  • Patent portfolio management
  • INTA confronts trademark issues
  • Developing an IP framework for the public sector
  • IP management in Nigeria


Payment types accepted